India  

Novavax

American biotechnology company

Novavax    ▸ Facts   ▸ Comments   ▸ News   ▸ Videos   

Novavax: American biotechnology company
Novavax, Inc., is an American biotechnology company based in Gaithersburg, Maryland that develops vaccines to counter serious infectious diseases. Prior to 2020, company scientists developed experimental vaccines for Ebola, influenza, respiratory syncytial virus (RSV), and other emerging infectious diseases. During 2020, the company redirected its efforts to focus on development and approval of its vaccine for COVID-19. Novavax has indicated it recognizes a continued need for innovative vaccines in other therapeutic areas and reports it has taken steps to ensure continued advancement of its influenza vaccine.

0
shares
ShareTweetSavePostSend
 
Serum Institute begins production of Novavax | 50 cases of Delta Plus in India | Oneindia News [Video]

Serum Institute begins production of Novavax | 50 cases of Delta Plus in India | Oneindia News

Union Minister for IT Ravi Shankar Prasad tweeted that the microblogging platform had denied him access to his account arbitrarily; As many as 48 coronavirus cases of Delta Plus variant have been..

Credit: Oneindia     Duration: 03:02Published
Covid19: Serum Institute of India to start trials of Novavax vaccine for kids in July| Oneindia News [Video]

Covid19: Serum Institute of India to start trials of Novavax vaccine for kids in July| Oneindia News

The Serum Institute of India (SII) hopes to start the clinical trials of Novavax's Covid-19 vaccine 'Covovax' on children in July. The SII is also planning to introduce 'Covovax' its version of the US..

Credit: Oneindia     Duration: 01:47Published

Novavax vaccine over 90% effective in U.S. trial [Video]

Novavax vaccine over 90% effective in U.S. trial

Novavax Inc on Monday reported late-stage data from its U.S.-based clinical trial showing its vaccine is more than 90% effective against COVID-19 across a variety of variants of the virus. Emer..

Credit: Reuters - Politics     Duration: 01:41Published
Pinellas Suncoast Transit Authority bus driver takes part in Novavax COVID-19 vaccine trial [Video]

Pinellas Suncoast Transit Authority bus driver takes part in Novavax COVID-19 vaccine trial

Pinellas Suncoast Transit Authority bus driver takes part in Novavax COVID-19 vaccine trial

Credit: ABC Action News     Duration: 01:53Published

You Might Like


Novavax vaccine efficacy data promising, encouraging: Govt


IndiaTimes - Published

COVID-19: Serum Institute's Novavax vaccine shows 90% overall efficacy

Novavax in collaboration with Indian drug manufacturer Serum Institute of India is manufacturing these vaccines for India and low-income countries.
DNA - Published

US to ease Covid vaccine input supply: Kamala Harris to PM Modi

US Vice-President Kamala Harris on Thursday spoke to PM Narendra Modi to brief him about the Biden administration’s new vaccine policy that will clear supply chains for AstraZeneca and Novavax..
IndiaTimes - Published

'I'm hoping collaboration can continue across borders' says Novavax vaccine maker

'i'm hoping collaboration can continue across borders' says novavax vaccine maker
The British manufacturer of the next coronavirus vaccine likely to be approved for general use in the UK has called on international governments to cooperate to ensure the global rollout is not..
Sky News - Published

Indian vaccine maker asks US to ease export curbs

Ramping up the production of this shot could also help India. Novavax has applied for emergency use of the vaccine to regulators in Europe, the US, and the World Health Organization.
IndiaTimes - Published

Pfizer, J&J vaccine rollout in India could take a few months

US pharma giants Pfizer, Johnson & Johnson, and Novavax could be among the potential gainers from the government’s decision on Tuesday to fast-track approvals for foreign-produced Covid-19 vaccines..
IndiaTimes - Published

Serum Institute of India plans to launch Covovax by June: Adar Poonawalla

SII CEO Adar Poonawalla said on Saturday that its partnership for a Covid-19 vaccine with Novavax has shown excellent efficacy results. "We have applied for starting trials in India. Hope to launch..
IndiaTimes - Published

COVID-19: Is India to get one more coronavirus vaccine, here's what SII CEO Adar Poonawalla said

The vaccine is being developed in partnership with American vaccine developer Novavax.
DNA - Published

Serum Institute applies to conduct local trial for Novavax vaccine: CEO

The Serum Institute of India (SII), the world's biggest vaccine maker, has applied to local authorities to conduct a small domestic trial of Novavax Inc's COVID-19 vaccine, which was found to be 89.3%..
IndiaTimes - Published

Easier to store than the Pfizer jab and cheaper: What we know about the Novavax vaccine

easier to store than the pfizer jab and cheaper: what we know about the novavax vaccine
A jab made by the US firm Novavax could become the fourth vaccine to be approved in the UK after promising data from a late-stage trial emerged.
Sky News - Published

UK trials show experimental Novavax coronavirus vaccine is 89.3% effective

UK phase three trials of the experimental Novavax COVID-19 vaccine have found it demonstrated 89.3% efficacy against the virus.
Sky News - Published

India to get 100 million doses of Oxford COVID-19 vaccine by Dec, says Adar Poonawalla

SII, which has tied up with five developers, has so far made 40 million doses of AstraZeneca vaccine in the past two months and aims to start manufacturing Novavax's contender soon.
DNA - Published

India's Serum says produced 40 million doses of AstraZeneca Covid-19 vaccine

Serum Institute of India, the world's largest vaccine producer, said on Thursday it has made 40 million doses of AstraZeneca's potential Covid-19 vaccine, and would soon begin making Novavax's rival..
IndiaTimes - Published

Novavax aims for 2 billion Covid-19 vaccine doses with expanded India deal


IndiaTimes - Published